Eisai initiates submission of application data of lecanemab under the prior assessment consultation system in Japan with the aim of an earlier regulatory approval
STOCKHOLM, March 4, 2022 /PRNewswire/ -- BioArctic AB:s (publ) (Nasdaq Stockholm: BIOA B) associate Eisai has initiated a submission ...